Have you ever had to have a medical procedure, such as an MRI scan, that involves lying still in a tiny, confined place while loud noises roar around you?
Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. Now, Australian researchers think they may have found an answer: taking psilocybin before MRIs.
A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures.
Magnetic resonance imaging (MRI) is a vital diagnostic tool in the medical world. Using magnetic fields to penetrate and create cross-sectional images of the body allows doctors and other healthcare professionals to:
According to a 2011 study published in the International Journal Of Psychophysiology, the Official Journal of The International Organization Of Psychophysiology, some patients panic when confined to such a small area, making the diagnostic procedure difficult or even impossible.
While comfy MRIs are not its primary goal, this psychedelic research has provided solid preliminary evidence that the psychoactive compound found in magic mushrooms can help accomplish just that.
The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.”
After receiving a subtherapeutic dose (19 milligrams) of synthetic psilocybin sandwiched between two MRI exams:
Participant Michael Taylor found undergoing an MRI on psilocybin to be a truly “magical experience.” For him, the strange sounds of the machine morphed into an otherworldly melody that swept over him like a wave of happiness.
Taylor explained, “I felt myself smiling, laughing; I’m sure I giggled at one point,” he says. “I was thinking: ‘I can’t believe this is happening. Why don’t more people get to experience this?'”
The profound sense of unity and connection with his surroundings that came with psilocybin expanded beyond the machine, leading him to a deep understanding of being one with all of existence.
Thanks to the Australian government’s $15 million investment in researching psychedelics in 2022 and The Turner Institute recruiting 60 mentally healthy participants for the project, PsiConnect has become one of the most extensive clinical trials involving both brain imaging technology and psychedelics.
This research is a cutting-edge leap forward, leaving researchers hopeful that this, along with findings in prior studies, will shed light on how to possibly treat mental illnesses with psychedelics, as well as develop new drugs.
All imaging and behavioral data will be accessible to the public after the study is complete. This will offer professionals worldwide a chance to gain insight into this research, equipping them with valuable information they can apply in their own contexts.
The findings make clear that psilocybin may offer promise in managing stress and anxiety before an MRI, which are common triggers for a negative (if not impossible) experience. However, it is important to note that the study took place with a small sample size under controlled conditions. Therefore, further research would be needed to confirm whether this could succeed on a larger scale.
There is still much yet to learn about how psilocybin can work in a clinical setting. Still, PsiConnect’s initiative provides hope that could one day become a reality, making MRIs more bearable and providing diagnostic answers to millions of people who struggle with the fear of MRI machines.
In any case, there is something special about this science-backed magic mushroom revolution—one can only wonder what lies ahead.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Consuming alcohol heavily in young adulthood is associated with an increased likelihood of developing alcohol use disorder (AUD), the most widespread substance-related disorder worldwide. Research has already shed light on the effects of individual differences like alcohol sensitivity and cardiovascular responses in predicting binge drinking behaviors and progression to AUD. However, there remains a gap…
Kentucky is once again exploring medical cannabis legalization, D.C. made good on its expungement promises, and Minnesota okayed a psychedelic task force. Let’s dive into this week’s cannanews. Kentucky Inches Toward Medical Cannabis Legalization Earlier this week, Kentucky’s State Senate passed a new proposal that seeks to legalize medical cannabis in the state. Under the…
The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. On Tuesday, January 24, several legislative bills were unveiled by the Japanese government. One of the proposed bills would amend the Cannabis Control Law…
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. One psychedelic that’s been getting a whole lot of attention lately is psilocybin, an active ingredient in mushroom species that are often called “magic mushrooms.” Psilocybin is a naturally…
Missouri is home to an estimated population of roughly 6 million residents. The state is popular for the agriculture industry, barbecue, and historic landmarks like the Gateway Arch. Missouri borders eight states and is a gateway to adventure in the land of legal cannabis. Six of the eight states surrounding Missouri have very strict cannabis…
At one time, there was a sign coming into Las Vegas that read, “Don’t gamble with marijuana.” In Nevada, possession equals 20…
Maryland and Delaware are exploring their cannabis policies, a Texas representative introduced another decriminalization bill, and New Orleans okayed cannabis-infused seltzers. Let’s…
Who would have thought that cannabis cultivation could be Alaska’s biggest earner? Over the course of the next eight years, marijuana cultivation…